Serving leading biopharmaceutical companies globally:

Last Updated: February 22, 2020

DrugPatentWatch Database Preview

Carlisle Company Profile

Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for CARLISLE, and what generic and branded alternatives to CARLISLE drugs are available?

CARLISLE has six approved drugs.

Summary for Carlisle

US Patents:	0
Tradenames:	3
Ingredients:	3
NDAs:	6

Drugs and US Patents for Carlisle

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Carlisle	ALPHACAINE	lidocaine	OINTMENT;TOPICAL	084944-001	Approved Prior to Jan 1, 1982		DISCN	No	No		Start Trial				Start Trial
Carlisle	ALPHACAINE HYDROCHLORIDE	lidocaine hydrochloride	INJECTABLE;INJECTION	084721-001	Approved Prior to Jan 1, 1982		DISCN	No	No		Start Trial				Start Trial
Carlisle	ALPHACAINE	lidocaine	OINTMENT;TOPICAL	084947-001	Approved Prior to Jan 1, 1982		DISCN	No	No		Start Trial				Start Trial
Carlisle	ALPHACAINE HYDROCHLORIDE W/ EPINEPHRINE	epinephrine; lidocaine hydrochloride	INJECTABLE;INJECTION	084720-001	Approved Prior to Jan 1, 1982		DISCN	No	No		Start Trial				Start Trial
Carlisle	ALPHACAINE	lidocaine	OINTMENT;TOPICAL	084946-001	Approved Prior to Jan 1, 1982		DISCN	No	No		Start Trial				Start Trial
Carlisle	ALPHACAINE HYDROCHLORIDE W/ EPINEPHRINE	epinephrine; lidocaine hydrochloride	INJECTABLE;INJECTION	084732-001	Approved Prior to Jan 1, 1982		DISCN	No	No		Start Trial				Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys

Johnson and Johnson

McKinsey

Dow

Baxter

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.